RareWays is a research directory. It helps you understand the science. It is not medical advice. Always discuss your care options with your healthcare team.
Coverage: 2020-01-01 onwards, with up to 300 results per query from PubMed and Europe PMC and separate limits on other sources. This is a selected index, not a complete literature search.
Updates are delayed or unverified. Check original sources for the latest information.
Your saved research and appointment questionsView recorded trial and retraction changes
Squamous Cell Carcinoma of the Cervix Uteri: Research Summary
Printed from RareWays (rareways.org)
For general awareness only. Not medical advice. Discuss all care options with your healthcare team.
5 Most Recent Research Articles
- 1.
Association of Systemic Immune-Inflammation Index and Systemic Inflammation Response Index with tumour grade and stage in Cervical Squamous Cell Carcinoma: A Cross-Sectional Study in South India
, International Journal of Drug Delivery Technology (18 October 2026)
https://doi.org/10.25258/ijddt.16.75s.144
- 2.
Enhancing cervical squamous cell carcinoma diagnosis under distribution shift via domain-adaptive representation learning
Zirui Huang et al., iScience (16 October 2026)
https://doi.org/10.1016/j.isci.2026.117744
- 3.
Prevalence and independent influencing factors of moderate-to-severe cancer-related fatigue (CRF) and its association with Buzhong-Yiqi (BZYQ) use among patients with locally advanced cervical squamous cell carcinoma (LACSCC): a retrospective observational study using propensity-score weighting (PSW) logistic regression model.
Li Chan et al., Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer (10 October 2026)
https://pubmed.ncbi.nlm.nih.gov/42859257/
- 4.
MULTI-TASK SURVIVAL PREDICTION IN EARLY-STAGE CERVICAL SQUAMOUS CELL CARCINOMA USING AN IMMUNOHISTOCHEMISTRY-INTEGRATED PATHOLOGY MODEL
Yangyang Zhang et al., International Journal of Gynecological Cancer (1 October 2026)
https://doi.org/10.1016/j.ijgc.2026.105182
- 5.
HPV low-risk associated squamous cell carcinoma of the cervix uteri
LC Horn et al., Geburtshilfe und Frauenheilkunde (1 October 2026)
https://doi.org/10.1055/s-0046-1828300
Clinical Trials : Currently Recruiting (Australia)
Ask your doctor whether you or your child may be eligible for any of these trials. Each has its ID and full eligibility criteria at the link shown.
- 1.
A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
NCT05910827 · Recruiting · Phase 1 / Phase 2 · Hummingbird Bioscience
Ages 18 and over
https://clinicaltrials.gov/study/NCT05910827
Source: RareWays research directory. Data from PubMed, Europe PMC, OpenAlex, ClinicalTrials.gov.
Always verify information with your healthcare team before making any decisions about your care.
Squamous Cell Carcinoma of the Cervix Uteri
Squamous cell carcinoma of the cervix is a cancer that starts in the flat surface cells covering the cervix, the lower part of the uterus. It is the most common type of cervical cancer and is usually linked to long-term infection with high-risk human papillomavirus. Treatment depends on the stage and may include surgery, radiotherapy, chemotherapy and immunotherapy.
This overview is general information, not an individual medical assessment. Research is selected automatically and may include mismatches. How we select and explain research.
Most Recent Research
Common Questions
What is Squamous Cell Carcinoma of the Cervix Uteri?
Squamous cell carcinoma of the cervix is a cancer that starts in the flat surface cells covering the cervix, the lower part of the uterus. It is the most common type of cervical cancer and is usually linked to long-term infection with high-risk human papillomavirus. Treatment depends on the stage and may include surgery, radiotherapy, chemotherapy and immunotherapy.
How many clinical trials are available for Squamous Cell Carcinoma of the Cervix Uteri?
RareWays currently indexes 74 clinical trials for Squamous Cell Carcinoma of the Cervix Uteri, of which 8 are actively recruiting. These counts cover indexed trials across countries, not just your country. An Australian site does not necessarily mean that site is recruiting. Check locations, eligibility and current availability with the study team.
Where does the research data for Squamous Cell Carcinoma of the Cervix Uteri come from?
RareWays aggregates research from PubMed, Europe PMC, OpenAlex, and ClinicalTrials.gov. Data is refreshed automatically every day. All articles and trials link directly to their original sources.
Get research updates
Monthly email when new findings are published for Squamous Cell Carcinoma of the Cervix Uteri.
Your email and selected disease are stored for these updates. Unsubscribe any time. Privacy and deletion.
This information is for general awareness only.
For guidance specific to your situation, please speak with your healthcare team.